REP. DINGELL’s LEGISLATIVE SCHEDULE FOR FDA EMERGENCY BILL CALLS FOR ENERGY & COMMERCE COMMITTEE ACTION IN JULY; WAXMAN OPPOSES FOCUS ON GENERICS